In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Capmatinib inhibits MET phosphorylation by hepatocyte growth factor binding or t···【more】
Release date:2024-08-06Recommended:324
Fidaxomicin is prescribed for the management of Clostridium difficile associated···【more】
Release date:2024-08-05Recommended:356
Fidaxomicin received its initial approval from the Food and Drug Administration ···【more】
Release date:2024-08-05Recommended:389
Fidaxomicin, a potent macrolide antibiotic renowned for its ability to impede ba···【more】
Release date:2024-08-05Recommended:397
Clostridium difficile, a prevalent enteric pathogen, is known to induce profound···【more】
Release date:2024-08-05Recommended:366
Fidaxomicin, a macrolide antibiotic sanctioned by the US FDA in 2011, boasts a d···【more】
Release date:2024-08-05Recommended:393
Fidaxomicin, a potent macrolide antibiotic, is primarily utilized in the treatme···【more】
Release date:2024-08-05Recommended:344
Fidaxomicin is a pharmaceutical agent specifically indicated for the treatment o···【more】
Release date:2024-08-05Recommended:306
Fidaxomicin, a potent antibiotic medication, serves as a pivotal remedy for the ···【more】
Release date:2024-08-05Recommended:358
Anamorelin represents a pioneering intervention for cancer-associated cachexia, ···【more】
Release date:2024-08-05Recommended:401
Through its distinctive mechanism of action, Anamorelin presents novel therapeut···【more】
Release date:2024-08-05Recommended:332
Fidaxomicin is indicated for the treatment of difficult Clostridioides difficile···【more】
Release date:2024-08-05Recommended:441